These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3436054)

  • 21. Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout.
    Dalbeth N; Phipps-Green A; House ME; Gamble GD; Horne A; Stamp LK; Merriman TR
    Arthritis Res Ther; 2015 Sep; 17(1):263. PubMed ID: 26391224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.
    Minisola S; Scarnecchia L; Carnevale V; Bigi F; Romagnoli E; Pacitti MT; Rosso R; Mazzuoli GF
    J Endocrinol Invest; 1989 Sep; 12(8):537-42. PubMed ID: 2592739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma urate, creatinine, alkaline phosphatase and the 24 hours excretion of hydroxyproline during sexual maturation in adolescents.
    Round JM
    Ann Hum Biol; 1980; 7(1):83-8. PubMed ID: 7396407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urate kinetics in hypoxanthine-guanine phosphoribosyltransferase deficiency: their significance for the understanding of gout.
    Emmerson BT; Gordon RB; Johnson LA
    Q J Med; 1976 Jan; 45(177):49-61. PubMed ID: 769040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hyperparathyroidism and proximal renal tubular acidosis: report of two cases.
    Siddiqui AA; Wilson DR
    Can Med Assoc J; 1972 Mar; 106(6):654-9. PubMed ID: 5012229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum alkaline phosphatase isoenzymes in primary hyperparathyroidism].
    Kalinin AP; Fekson EG; Firsov BM
    Lab Delo; 1978; (12):710-2. PubMed ID: 82662
    [No Abstract]   [Full Text] [Related]  

  • 29. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic control of the renal clearance of urate: a study of twins.
    Emmerson BT; Nagel SL; Duffy DL; Martin NG
    Ann Rheum Dis; 1992 Mar; 51(3):375-7. PubMed ID: 1575585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease.
    Mohammed SM; Suleiman SA; Addae SK; Annobil SH; Adzaku FK; Kadoummi OF; Richards JT
    Clin Chim Acta; 1991 Dec; 203(2-3):285-94. PubMed ID: 1777988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC; Ma WY; Yu JC; Wu CC; Chu P
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.
    Gibson T; Sims HP; Jimenez SA
    Ann Rheum Dis; 1976 Aug; 35(4):372-6. PubMed ID: 970997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.
    Calabrese G; Simmonds HA; Cameron JS; Davies PM
    Q J Med; 1990 May; 75(277):441-50. PubMed ID: 2388995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone isoenzyme of serum alkaline phosphatase in acromegaly.
    Stĕpán J; Marek J; Havránek T; Dolezal V; Pacovský V
    Clin Chim Acta; 1979 May; 93(3):355-63. PubMed ID: 36248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical assessment of bone disease in multiple myeloma.
    Stĕpán JJ; Neuwirtová R; Pacovský V; Formánková J; Silinková-Málková E
    Clin Chim Acta; 1984 Sep; 142(2):203-9. PubMed ID: 6499205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A supplement to alkaline phosphatase fractionations: utilization of gamma-glutamyl transpeptidase and hydroxyproline assays.
    Slaunwhite D; Tuggey RL; Reynoso G
    Ann Clin Lab Sci; 1978; 8(2):117-21. PubMed ID: 25040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study.
    Dalbeth N; House ME; Aati O; Tan P; Franklin C; Horne A; Gamble GD; Stamp LK; Doyle AJ; McQueen FM
    Ann Rheum Dis; 2015 May; 74(5):908-11. PubMed ID: 25637002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.